losartan has been researched along with calcitriol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cao, K; Goltzman, D; Lu, F; Miao, D; Xu, D; Zhou, C | 1 |
| Kozlovskaia, LV; Milovanov, IuS; Milovanova, LIu | 1 |
| Chandel, N; Goel, H; Husain, M; Lan, X; Malhotra, A; McGowan, J; Salhan, D; Singhal, PC | 1 |
| Coimbra, TM; Costa, RS; da Silva, CGA; de Almeida, LF; Francescato, HDC | 1 |
| Dong, J; Gao, M; Li, Y; Liu, Y; Suo, Z; Xu, C | 1 |
2 review(s) available for losartan and calcitriol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys].
Topics: Angiotensin II Type 1 Receptor Blockers; Calcitriol; Cardiovascular Diseases; Chronic Disease; Ergocalciferols; Humans; Kidney Diseases; Losartan | 2011 |
7 other study(ies) available for losartan and calcitriol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Animals; Antihypertensive Agents; Blood Pressure; Calcium; Captopril; Cardiomegaly; Gene Deletion; Gene Targeting; Hypertension; Losartan; Mice; Mice, Knockout; Myocytes, Cardiac; Phosphorus; Renin-Angiotensin System; Vitamin D | 2008 |
VDR hypermethylation and HIV-induced T cell loss.
Topics: Angiotensin II Type 1 Receptor Blockers; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Calcitriol; Catalase; Cells, Cultured; CpG Islands; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; DNA Repair; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; HIV-1; Humans; Losartan; Lymphocyte Count; ras Proteins; Reactive Oxygen Species; Receptors, Calcitriol; T-Lymphocytes | 2013 |
Calcitriol reduces kidney development disorders in rats provoked by losartan administration during lactation.
Topics: Animals; Biomarkers; Biopsy; Blood Pressure; Body Weight; Breast Feeding; Calcitriol; Chemokine CCL2; Congenital Abnormalities; Disease Models, Animal; Female; Immunohistochemistry; Kidney; Kidney Diseases; Kidney Function Tests; Lactation; Losartan; Male; Rats; Transforming Growth Factor beta | 2017 |
Calcitriol inhibits COX-1 and COX-2 expressions of renal vasculature in hypertension: Reactive oxygen species involved?
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcitriol; Cyclic N-Oxides; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endothelium, Vascular; Free Radical Scavengers; Humans; Hypertension; Losartan; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Receptors, Calcitriol; Renal Artery; Spin Labels; Vasodilation | 2021 |